These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11748668)

  • 21. A quantitative immuno-PCR assay for the detection of mumps-specific IgG.
    McKie A; Samuel D; Cohen B; Saunders NA
    J Immunol Methods; 2002 Dec; 270(1):135-41. PubMed ID: 12379345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of neutralization test for laboratory diagnosis of suspected mumps.
    Vaidya SR; Hamde VS; Kumbhar NS; Walimbe AM
    Microbiol Immunol; 2018 Apr; 62(4):243-247. PubMed ID: 29363797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.
    Gabriel M; Adomeh DI; Ehimuan J; Oyakhilome J; Omomoh EO; Ighodalo Y; Olokor T; Bonney K; Pahlmann M; Emmerich P; Lelke M; Brunotte L; Ölschläger S; Thomé-Bolduan C; Becker-Ziaja B; Busch C; Odia I; Ogbaini-Emovon E; Okokhere PO; Okogbenin SA; Akpede GO; Schmitz H; Asogun DA; Günther S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006361. PubMed ID: 29596412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody capture radioimmunoassay for anti-rubella IgM.
    Mortimer PP; Tedder RS; Hamblig MH; Shafi MS; Burkhardt F; Schilt U
    J Hyg (Lond); 1981 Apr; 86(2):139-53. PubMed ID: 7462599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections.
    Saijo M; Tang Q; Shimayi B; Han L; Zhang Y; Asiguma M; Tianshu D; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2005 Feb; 75(2):295-9. PubMed ID: 15602720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
    Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S
    J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An M-antibody capture radioimmunoassay (MACRIA) for detection of JC virus-specific IgM.
    Knowles WA; Gibson PE; Hand JF; Brown DW
    J Virol Methods; 1992 Oct; 40(1):95-105. PubMed ID: 1331163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test.
    Morinet F; Courouce AM; Galibert F; Perol Y
    J Virol Methods; 1991 Apr; 32(1):21-30. PubMed ID: 1648571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of immunoglobulin G titer for the diagnosis of mumps virus in infected patients depending on vaccination status.
    Sanz JC; Mosquera Mdel M; Echevarría JE; Fernández M; Herranz N; Palacios G; De Ory F
    APMIS; 2006 Nov; 114(11):788-94. PubMed ID: 17078860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The enzyme-linked immunosorbent assay (ELISA) for determination of IgG and IgM antibodies after infection with mumps virus.
    Nicolai-Scholten ME; Ziegelmaier R; Behrens F; Höpken W
    Med Microbiol Immunol; 1980; 168(2):81-90. PubMed ID: 7453669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of antibody capture radio- and enzyme immunoassays with immunofluorescence for detecting IgM antibody in infants with congenital rubella.
    Chantler S; Evans CJ; Mortimer PP; Cradock-Watson JE; Ridehalgh MK
    J Virol Methods; 1982 Aug; 4(6):305-13. PubMed ID: 6752160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG.
    Patou G; Ayliffe U
    J Clin Pathol; 1991 Oct; 44(10):831-4. PubMed ID: 1660053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.
    Rota JS; Rosen JB; Doll MK; McNall RJ; McGrew M; Williams N; Lopareva EN; Barskey AE; Punsalang A; Rota PA; Oleszko WR; Hickman CJ; Zimmerman CM; Bellini WJ
    Clin Vaccine Immunol; 2013 Mar; 20(3):391-6. PubMed ID: 23324519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection.
    Sakata R; Nagita A; Kidokoro M; Kato A; Ogino K
    Pediatr Res; 2015 Nov; 78(5):580-4. PubMed ID: 26267156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [IgM antibody detection in acute viral diseases, 1995-2004: analysis of data collected at a commercial diagnostic laboratory in Japan].
    Ban F; Itabashi Y; Masui Y; Inouye S
    Kansenshogaku Zasshi; 2007 Jul; 81(4):426-34. PubMed ID: 17695798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An amplified ELISA for the detection of parvovirus B19 IgM using monoclonal antibody to FITC.
    Brown KE; Buckley MM; Cohen BJ; Samuel D
    J Virol Methods; 1989 Nov; 26(2):189-98. PubMed ID: 2515204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution to laboratory diagnosis of mumps and parainfluenza.
    Franková V; Holubová J; Grubhoffer L; Kasová V
    Acta Virol; 1988 Nov; 32(6):503-14. PubMed ID: 2906222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.
    Morgan-Capner P; McSorley C
    J Hyg (Lond); 1983 Jun; 90(3):333-49. PubMed ID: 6306097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.